NO140820C - Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonylurinstoffderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonylurinstoffderivater

Info

Publication number
NO140820C
NO140820C NO740532A NO740532A NO140820C NO 140820 C NO140820 C NO 140820C NO 740532 A NO740532 A NO 740532A NO 740532 A NO740532 A NO 740532A NO 140820 C NO140820 C NO 140820C
Authority
NO
Norway
Prior art keywords
sulphonylurine
derivatives
preparation
therapeutically active
analogical procedure
Prior art date
Application number
NO740532A
Other languages
English (en)
Norwegian (no)
Other versions
NO740532L (no
NO140820B (no
Inventor
Donald Ernest Kuhla
Hans Eberhardt Wiedermann
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO740532L publication Critical patent/NO740532L/no
Publication of NO140820B publication Critical patent/NO140820B/no
Publication of NO140820C publication Critical patent/NO140820C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
NO740532A 1973-03-07 1974-02-18 Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonylurinstoffderivater NO140820C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00338965A US3856806A (en) 1973-03-07 1973-03-07 Thiazolecarboxamide sulfonylurea hypoglycemic agents

Publications (3)

Publication Number Publication Date
NO740532L NO740532L (no) 1974-09-10
NO140820B NO140820B (no) 1979-08-13
NO140820C true NO140820C (no) 1979-11-21

Family

ID=23326893

Family Applications (1)

Application Number Title Priority Date Filing Date
NO740532A NO140820C (no) 1973-03-07 1974-02-18 Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonylurinstoffderivater

Country Status (29)

Country Link
US (1) US3856806A (fr)
JP (1) JPS5418258B2 (fr)
AR (1) AR201135A1 (fr)
AT (1) AT342614B (fr)
AU (1) AU458655B2 (fr)
BE (1) BE811866A (fr)
BG (1) BG25376A3 (fr)
CA (1) CA1015362A (fr)
CH (1) CH581639A5 (fr)
CS (1) CS176268B2 (fr)
DD (1) DD110500A5 (fr)
DE (1) DE2410003A1 (fr)
DK (1) DK139579B (fr)
EG (1) EG11270A (fr)
ES (1) ES423865A1 (fr)
FI (1) FI55034C (fr)
FR (1) FR2220259B1 (fr)
GB (1) GB1409518A (fr)
HU (1) HU167511B (fr)
IE (1) IE38955B1 (fr)
IL (1) IL44230A (fr)
LU (1) LU69565A1 (fr)
NL (1) NL7402804A (fr)
NO (1) NO140820C (fr)
PL (1) PL96884B1 (fr)
RO (1) RO69724A (fr)
SE (1) SE393984B (fr)
SU (1) SU617012A3 (fr)
ZA (1) ZA741439B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714920D0 (en) * 1987-06-25 1987-07-29 Shell Int Research Thiazole derivatives

Also Published As

Publication number Publication date
DK139579B (da) 1979-03-12
EG11270A (en) 1977-08-15
NO740532L (no) 1974-09-10
SE393984B (sv) 1977-05-31
IL44230A0 (en) 1974-05-16
ES423865A1 (es) 1976-03-16
AU6586474A (en) 1975-03-06
AT342614B (de) 1978-04-10
JPS5418258B2 (fr) 1979-07-06
NO140820B (no) 1979-08-13
GB1409518A (en) 1975-10-08
FI55034B (fi) 1979-01-31
BG25376A3 (en) 1978-09-15
CH581639A5 (fr) 1976-11-15
FR2220259B1 (fr) 1977-10-28
DK139579C (fr) 1979-08-27
PL96884B1 (pl) 1978-01-31
DE2410003A1 (de) 1974-09-26
AR201135A1 (es) 1975-02-14
FI55034C (fi) 1979-05-10
FR2220259A1 (fr) 1974-10-04
CS176268B2 (fr) 1977-06-30
RO69724A (fr) 1981-04-30
HU167511B (fr) 1975-10-28
IE38955B1 (en) 1978-07-05
LU69565A1 (fr) 1974-10-09
US3856806A (en) 1974-12-24
JPS5029557A (fr) 1975-03-25
IE38955L (en) 1974-09-07
AU458655B2 (en) 1975-03-06
SU617012A3 (ru) 1978-07-25
BE811866A (fr) 1974-09-05
ATA174074A (de) 1977-08-15
CA1015362A (en) 1977-08-09
NL7402804A (fr) 1974-09-10
ZA741439B (en) 1975-02-26
DD110500A5 (fr) 1974-12-20
IL44230A (en) 1976-12-31

Similar Documents

Publication Publication Date Title
NO140424C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolderivater
NO137440C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pleuromutiliner
NO141013C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive bifenylyl-derivater
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO140597C (no) Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater
NO140671C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepiner
NO140978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO138336C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzofuranderivater
NO140496C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
NO140821C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater
NO140596C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktive hydroksyalkylxantiner
NO140012C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin
NO140670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO139386C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive imidazopyridiner
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO138063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO138561C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme cykloalkylfenoksykarboksylsyrederivater
NO138250C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylaminer
SE402111B (sv) Analogiforfarande for framstellning av pregnansyraderivat
NO140062C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminoderivater av pyrazolopyridin-ketoner
NO139733C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av metylamin